Inspyr Therapeutics Inc (OTC Pink - No Information:NSPX)

0.01
Delayed Data
As of May 18
 0.00 / 0.00%
Today’s Change
0.01
Today|||52-Week Range
0.55
-60.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization5.0K6.0K4.0K13.0K
 
 
 
 
 
 
Operating ExpensesGross Income-5.0K-6.0K-4.0K-13.0K
 
 
 
 
 
General Expenses560.0K919.0K817.0K845.0K
 
 
 
 
 
Research And Development76.0K465.0K500.0K384.0K
 
 
 
 
 
Total Operating Expenses565.0K925.0K821.0K858.0K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-565.0K-925.0K-821.0K-858.0K
 
 
 
 
 
Extraordinary Credit2.1M1.7M315.0K1.4M
 
 
 
 
 
Interest Expense On Debt2.9M1.4M0.005.0M
 
 
 
 
Other Expenses0.000.00-45.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.4M-659.0K-551.0K-4.4M
 
 
 
 
 
Net Income-1.4M-659.0K-551.0K-4.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.4M1.5M1.6M6.4M
 
 
 
 
 
Shares To Calculate EPS Diluted1.4M1.5M1.6M6.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.97-$0.45-$0.35-$0.69
 
 
 
 
 
EPS Diluted-$0.97-$0.45-$0.35-$0.69